WinstonWınston
Teladoc Health logo

Teladoc Health

TDOC
19
Medical - Healthcare Information Services · Healthcare
Price
$9.43
-0.04 (-0.42%)
Market Cap
$1.70B
Winston Score
19
Winston is worried
Weak fundamentals across most pillars.

Share count rising — dilution

+12.3% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 156.9M (2021) → 176.2M (2025)

Teladoc Health lets people see a doctor without leaving home. Patients use an app or website to video chat with doctors, therapists, and other health professionals. The company serves millions of individual members, but its biggest customers are employers and health insurance plans that pay for their workers or members to use the service.

Teladoc makes most of its money by charging employers and insurers a recurring fee per member, plus additional fees when members actually use the service. It operates mainly in the United States but also has customers in over 130 countries. Teladoc is one of the largest telehealth companies in the world, which gives it scale, but it faces heavy competition from traditional health systems and newer digital health startups. The company has struggled to turn a profit, and its biggest challenge is convincing enough members to actually use the service regularly so that revenue grows faster than its costs.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-2.5% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+32.1% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$278M/ year

Declining (-10% vs prior year)

11.0% of revenue

Below sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

2.6%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Position

Cash flow positive

$751M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

Teladoc Health's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
52.8%
Healthy — 52.8% gross margin
Operating Margin
-7.9%
Losing money on operations — -7.9%
ROCE
-2.1%
Weak — -2.1% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-1.5%
Shrinking sales (-1.5% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
10.0%
Modest free cash flow (10.0%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.75
Moderate — manageable debt (0.75)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial